Senator Requests Study on Uniting Federal IP Offices Into Single Office

copyright patent trademark

U.S. Senator Thom Tillis (R-NC) has requested the Administrative Conference of the United States, the federal agency tasked with making federal functions more efficient, to conduct a study into the feasibility of having a unified, singular federal office devoted to intellectual property, combining the registration and prosecution functions currently handled by both the United States …

Continue Reading

Comment Period on Patent Eligibility Extended

101 IP Practicum patent patent eligible subject matter

On September 2, 2021, the U.S. Patent and Trademark Office extended the deadline for submission of comments regarding the state of patent eligibility and its effectiveness on U.S. investments and innovation.  The new date is October 15, 2021. The USPTO issued a notice on the Federal Register on July 9, 2021, requesting comments on patent …

Continue Reading

U.S. Patent No. 10,888,283 B1

COVID patent Tech Patents

U.S. Patent No. 10,888,283 B1 (‘283), issued on January 12, 2021, to applicants/inventors Boonsieng Benjauthrit, Sorapod B. Benjauthrit, Vatcharee L. Benjauthrit, and Kamolchanok J. Benjauthrit, all of La Cañada, California.  The claims are directed to an apparatus called a COVID-19 Symptoms Alert Machine (CSAM) scanning device comprising the scanner, temperature scanner, a patient-provided health information …

Continue Reading

U.S. Patent No. 10,874,687 B1

COVID patent Tech Patents

U.S. Patent No. 10,874,687 B1 (‘687), issued on December 29, 2020, to inventors Jean-Pierre Sommadossi of Boston, Massachusetts, and Adel Moussa of Burlington, Massachusetts.  The applicant/assignee is Atea Pharmaceuticals, Inc. of Boston, Massachusetts, an anti-viral drug developer. The claims are directed to a method of therapeutic use for treating COVID-19, comprising the purine nucleotide phosphoramidate …

Continue Reading

U.S. Patent No. D907,885 S1

COVID design patent Tech Patents

U.S. Patent No. D907,885 S1 (‘885) issued on January 21, 2021, for “Funerary Urn.”  It was issued to inventor Alex Borzaga of Cavareno, Italy.  The applicant/assignee is Fenicetek of Turin, Italy.  This patent is a design patent under 35 U.S.C. §171, which protects the ornamental features of an article of manufacture.  The features protect the …

Continue Reading

U.S. Patent No. 10,780,052 B2

COVID patent Tech Patents

U.S. Patent No. 10,780,052 (‘052) B2, issued on September 22, 2020, to inventors Frank DeRosa, Michael Heartlein, and Shirang Karve of Cambridge, Massachusetts, and applicant/assignee, Translate Bio, Inc., of Lexington, Massachusetts.  The ‘052 patent claims priority to a provisional application filed October 22, 2013. The claims are directed to a method of therapeutic delivery of …

Continue Reading

U.S. Patent No. PP31,874 P3

Cannabis IP patent plantIP

U.S. Patent No. PP31,874 P3 (‘874) issued on June 16, 2020 for “Cannabis Plant Named ‘Holy Crunch.”  It was issued to inventor Mark Anthony Lewis and Steven Robert Haba, of Westlake Village, California and applicant/assignee Biotech Institute, LLC of Westlake Village, California.  The ‘874 patent is a plant patent under 35 U.S.C. §161, which protects …

Continue Reading

U.S. Patent No. PP31,707 P3

Cannabis IP patent plant plantIP

U.S. Patent No. PP31,707 P3 (‘707) issued onapril 28, 2020, for “Cannabis Plant Named ‘Grape Lollipop’.”  It was issued to inventor Mark Anthony Lewis and Steven Robert Haba, of Westlake Village, California and applicant/assignee Biotech Institute, LLC of Westlake Village, California.  The ‘707 patent is a plant patent under 35 U.S.C. §161, which protects new …

Continue Reading

U.S. Patent No. 10,625,177 B2

Cannabis IP patent

U.S. Patent No. 10,625,177 B2 (‘177) issued on April 21, 2020, for “Bioavailable Cannabis Plant Blend.”  It was issued to inventor David Harold Moore of Henderson, Nevada.  The inventor discusses in the background of the specification how he has Asperger’s Syndrome, a mild form of autism.  This autism can lead to an autoimmune disorder causing …

Continue Reading

Presidential Inauguration Day

copyright patent trademark

This is something trivial, but important to the daily IP practice.  Consistent with 5 U.S.C. §6103(c), which deems “January 20 of each fourth year after 1965, Inauguration Day, is a legal public holiday . . . . ,” the USPTO is closed.  The Copyright Office is also closed for the presidential inauguration.  Any deadlines that …

Continue Reading